share_log

Piper Sandler Maintains Neutral on Globus Medical, Raises Price Target to $60

Benzinga ·  May 8 12:03

Piper Sandler analyst Matt O'Brien maintains Globus Medical (NYSE:GMED) with a Neutral and raises the price target from $55 to $60.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment